IL17A and graft versus host disease: This is in line with published literature describing a role of donor-derived IL-17 in gut GVHD [16], but in contrast with research done by Kappel et al. which showed an ameliorated GVHD in the absence of donor IL-17A, albeit using a different experimental setup [15].